Insider · CIK 0001913897
Scott N Boyle
officer
Files at CCCC (C4 Therapeutics, Inc.). First filing Feb 18, 2025, latest Feb 18, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $3,651 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CCCC: C4 Therapeutics, Inc.
CCCCOct 9, 2026 · close 3.16
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | C4 Therapeutics, Inc. | $3,651 1,159 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | CCCC C4 Therapeutics, Inc. | FTax withholding Common Stock10b5-1 | -1,735 | $3.20 | $5,552 | 54,832 | Feb 18, 2025 |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | AGrant or award Common Stock10b5-1 | +56,500 | $0.00 | $0 | 111,332 | Feb 18, 2025 |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -490 | $3.15 | $1,544 | 110,842 | Feb 18, 2025 |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | FTax withholding Common Stock10b5-1 | -2,368 | $3.18 | $7,530 | 108,474 | Feb 18, 2025 |
| Feb 18, 2025 | CCCC C4 Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -669 | $3.15 | $2,107 | 107,805 | Feb 18, 2025 |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +84,700 | $0.00 | $0 | 84,700 | Feb 18, 2025 |
| Nov 7, 2024 | CCCC C4 Therapeutics, Inc. | MOption exercise Common Stock | +3,750 | - | - | 57,669 | Nov 12, 2024 |
| Nov 7, 2024 | CCCC C4 Therapeutics, Inc. | FTax withholding Common Stock | -1,102 | $6.04 | $6,656 | 56,567 | Nov 12, 2024 |
| Nov 7, 2024 | CCCC C4 Therapeutics, Inc. | MOption exercise Performance Restricted Stock Unitsderivative | -3,750 | $0.00 | $0 | 10,500 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.